Role and prognostic significance of CD44s expression in colorectal cancer

Paolo Visca, Franca Del Nonno, Claudio Botti, Ferdinando Marandino, Valeria Sebastiani, Ugo Di Tondo, Raffaele Perrone Donnorso, Giorgio Trombetta, Stefania Filippi, Piero Luigi Alo

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to clarify the role and the predictive strength of the adhesion molecule CD44s (standard isoform) in colorectal carcinogenesis. Materials and Methods: CD44s immunohistochemical expression was evaluated in 100 patients with colon adenoma and 100 patients with colon adenocarcinoma and adjacent non-neoplastic mucosa (ANNM). The patients were followed-up for five years. Results: CD44s immunoreactivity was expressed in low-moderate-high-grade dysplasia adenomas and associated with adenocarcinoma (p=0.01), ANNM (p=0.05) and pTNM stage (p=0.00001). Univariate analysis revealed that CD44s expression was associated with overall survival (OS) in carcinomas (p=0.01) and ANNM (p=0.05). Bivariate analysis revealed that CD44s was associated with OS in stages I and II patients (p=0.03). Multivariate analysis revealed that stage (p=0.0001) and CD44s expression (p=0.05) were independent predictors of OS. Conclusion: CD44s is involved in colon carcinogenesis and is associated with aggressive carcinomas. The immunohistochemical expression of CD44s may reveal cells that have lost their adhesion ability and therefore detect carcinomas with high metastatic power.

Original languageEnglish
Pages (from-to)2671-2675
Number of pages5
JournalAnticancer Research
Volume22
Issue number5
Publication statusPublished - Sep 2002

Fingerprint

Colorectal Neoplasms
Colon
Mucous Membrane
Carcinoma
Adenoma
Survival
Carcinogenesis
Adenocarcinoma
Protein Isoforms
Multivariate Analysis

Keywords

  • Carcinogenesis
  • CD44s
  • Colorectal
  • Immunohistochemistry
  • Prognosis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Visca, P., Del Nonno, F., Botti, C., Marandino, F., Sebastiani, V., Di Tondo, U., ... Alo, P. L. (2002). Role and prognostic significance of CD44s expression in colorectal cancer. Anticancer Research, 22(5), 2671-2675.

Role and prognostic significance of CD44s expression in colorectal cancer. / Visca, Paolo; Del Nonno, Franca; Botti, Claudio; Marandino, Ferdinando; Sebastiani, Valeria; Di Tondo, Ugo; Donnorso, Raffaele Perrone; Trombetta, Giorgio; Filippi, Stefania; Alo, Piero Luigi.

In: Anticancer Research, Vol. 22, No. 5, 09.2002, p. 2671-2675.

Research output: Contribution to journalArticle

Visca, P, Del Nonno, F, Botti, C, Marandino, F, Sebastiani, V, Di Tondo, U, Donnorso, RP, Trombetta, G, Filippi, S & Alo, PL 2002, 'Role and prognostic significance of CD44s expression in colorectal cancer', Anticancer Research, vol. 22, no. 5, pp. 2671-2675.
Visca P, Del Nonno F, Botti C, Marandino F, Sebastiani V, Di Tondo U et al. Role and prognostic significance of CD44s expression in colorectal cancer. Anticancer Research. 2002 Sep;22(5):2671-2675.
Visca, Paolo ; Del Nonno, Franca ; Botti, Claudio ; Marandino, Ferdinando ; Sebastiani, Valeria ; Di Tondo, Ugo ; Donnorso, Raffaele Perrone ; Trombetta, Giorgio ; Filippi, Stefania ; Alo, Piero Luigi. / Role and prognostic significance of CD44s expression in colorectal cancer. In: Anticancer Research. 2002 ; Vol. 22, No. 5. pp. 2671-2675.
@article{cbdd47423ff04b47bb0c046af41789be,
title = "Role and prognostic significance of CD44s expression in colorectal cancer",
abstract = "The purpose of this study was to clarify the role and the predictive strength of the adhesion molecule CD44s (standard isoform) in colorectal carcinogenesis. Materials and Methods: CD44s immunohistochemical expression was evaluated in 100 patients with colon adenoma and 100 patients with colon adenocarcinoma and adjacent non-neoplastic mucosa (ANNM). The patients were followed-up for five years. Results: CD44s immunoreactivity was expressed in low-moderate-high-grade dysplasia adenomas and associated with adenocarcinoma (p=0.01), ANNM (p=0.05) and pTNM stage (p=0.00001). Univariate analysis revealed that CD44s expression was associated with overall survival (OS) in carcinomas (p=0.01) and ANNM (p=0.05). Bivariate analysis revealed that CD44s was associated with OS in stages I and II patients (p=0.03). Multivariate analysis revealed that stage (p=0.0001) and CD44s expression (p=0.05) were independent predictors of OS. Conclusion: CD44s is involved in colon carcinogenesis and is associated with aggressive carcinomas. The immunohistochemical expression of CD44s may reveal cells that have lost their adhesion ability and therefore detect carcinomas with high metastatic power.",
keywords = "Carcinogenesis, CD44s, Colorectal, Immunohistochemistry, Prognosis",
author = "Paolo Visca and {Del Nonno}, Franca and Claudio Botti and Ferdinando Marandino and Valeria Sebastiani and {Di Tondo}, Ugo and Donnorso, {Raffaele Perrone} and Giorgio Trombetta and Stefania Filippi and Alo, {Piero Luigi}",
year = "2002",
month = "9",
language = "English",
volume = "22",
pages = "2671--2675",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5",

}

TY - JOUR

T1 - Role and prognostic significance of CD44s expression in colorectal cancer

AU - Visca, Paolo

AU - Del Nonno, Franca

AU - Botti, Claudio

AU - Marandino, Ferdinando

AU - Sebastiani, Valeria

AU - Di Tondo, Ugo

AU - Donnorso, Raffaele Perrone

AU - Trombetta, Giorgio

AU - Filippi, Stefania

AU - Alo, Piero Luigi

PY - 2002/9

Y1 - 2002/9

N2 - The purpose of this study was to clarify the role and the predictive strength of the adhesion molecule CD44s (standard isoform) in colorectal carcinogenesis. Materials and Methods: CD44s immunohistochemical expression was evaluated in 100 patients with colon adenoma and 100 patients with colon adenocarcinoma and adjacent non-neoplastic mucosa (ANNM). The patients were followed-up for five years. Results: CD44s immunoreactivity was expressed in low-moderate-high-grade dysplasia adenomas and associated with adenocarcinoma (p=0.01), ANNM (p=0.05) and pTNM stage (p=0.00001). Univariate analysis revealed that CD44s expression was associated with overall survival (OS) in carcinomas (p=0.01) and ANNM (p=0.05). Bivariate analysis revealed that CD44s was associated with OS in stages I and II patients (p=0.03). Multivariate analysis revealed that stage (p=0.0001) and CD44s expression (p=0.05) were independent predictors of OS. Conclusion: CD44s is involved in colon carcinogenesis and is associated with aggressive carcinomas. The immunohistochemical expression of CD44s may reveal cells that have lost their adhesion ability and therefore detect carcinomas with high metastatic power.

AB - The purpose of this study was to clarify the role and the predictive strength of the adhesion molecule CD44s (standard isoform) in colorectal carcinogenesis. Materials and Methods: CD44s immunohistochemical expression was evaluated in 100 patients with colon adenoma and 100 patients with colon adenocarcinoma and adjacent non-neoplastic mucosa (ANNM). The patients were followed-up for five years. Results: CD44s immunoreactivity was expressed in low-moderate-high-grade dysplasia adenomas and associated with adenocarcinoma (p=0.01), ANNM (p=0.05) and pTNM stage (p=0.00001). Univariate analysis revealed that CD44s expression was associated with overall survival (OS) in carcinomas (p=0.01) and ANNM (p=0.05). Bivariate analysis revealed that CD44s was associated with OS in stages I and II patients (p=0.03). Multivariate analysis revealed that stage (p=0.0001) and CD44s expression (p=0.05) were independent predictors of OS. Conclusion: CD44s is involved in colon carcinogenesis and is associated with aggressive carcinomas. The immunohistochemical expression of CD44s may reveal cells that have lost their adhesion ability and therefore detect carcinomas with high metastatic power.

KW - Carcinogenesis

KW - CD44s

KW - Colorectal

KW - Immunohistochemistry

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=0036765679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036765679&partnerID=8YFLogxK

M3 - Article

C2 - 12529980

AN - SCOPUS:0036765679

VL - 22

SP - 2671

EP - 2675

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5

ER -